Esperion Therapeutics, Inc.·4

Mar 17, 5:16 PM ET

Warren Eric 4

4 · Esperion Therapeutics, Inc. · Filed Mar 17, 2025

Insider Transaction Report

Form 4
Period: 2025-03-14
Warren Eric
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-03-14+191,000191,000 total
    Exercise: $1.50Exp: 2035-03-14Common Stock (191,000 underlying)
  • Award

    Common Stock

    2025-03-14+213,000372,759 total
Footnotes (1)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2025.

Documents

2 files